In particular, the effects of C5a deficiency and C5aR1 inhibition have been evaluated in mice with colorectal [42] and lung cancer [43], demonstrating the efficient reduction of tumor size and the enhancement of the effects of anti-cancer chemotherapy. Here, C5AR1 is linked to neoplasm.